Evidence map›Paper›PMID 28868500›Full record

ReviewInvestigative and clinical urology2017

Epidemiology and economics of nephrolithiasis.

Justin B Ziemba, Brian R Matlaga

Registry-linked trialOpen access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Investigative and clinical urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05218057 (TFL vs Ho), which is not on this map. Cited by 161 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
161citing papers in PubMed, 15 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05218057 nacompletednot on this mapstarted 2022, after this paper: background citation

TFL vs Ho:YAG - A Prospective Study to Compare the Effectiveness of Thulium Fiber Laser and Holmium YAG Laser for Ureteroscopic Lithotripsy

TypeinterventionalSponsorChinese University of Hong KongRan2022 to 2023Enrolled46ConditionsUreteric StoneArmsUreteroscopic lithotripsy
3 · Its place in the literature

Who cites it

161 citing papers in PubMed, 15 syntheses or guidelines pooled it, 334 citations in OpenAlex.

  1. SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Metabolic changes in kidney stone disease.Frontiers in immunology · 2023
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Impact of body mass index on size and composition of urinary stones: a systematic review and meta-analysis.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

101 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Justin B ZiembaDepartment of Urology, Brady Urological Institute, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Brian R MatlagaDepartment of Urology, Brady Urological Institute, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Johns Hopkins Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrolithiasis is a disease common in both the Western and non-Western world. Several population based studies have demonstrated a rising prevalence and incidence of the disease over the last several decades. Recurrence occurs frequently after an initial stone event. The influence of diet on the risk of nephrolithiasis is important, particularly dietary calcium and fluid intake. An increasing intake of dietary calcium and fluid are consistently associated with a reduced risk of incident nephrolithiasis in both men and women. Increasing evidence suggests that nephrolithiasis is associated with systemic diseases like obesity, diabetes, and cardiovascular disease. Nephrolithiasis places a significant burden on the health care system, which is likely to increase with time.

Indexed as

Delivery of Health CareDietEnvironmentHealth Care CostsHumansIncidenceNephrolithiasisPrevalenceRecurrenceRisk FactorsUnited StatesDietEpidemiologyKidney calculiNephrolithiasis

Identifiers

PMID28868500
PMCPMC5577325
OpenAlexW2753369228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.